IL6 and lung carcinoma: Besides that, evidence shows that a high abundance of calprotectin could be one of the main characteristics of lung cancer cells with bone metastatic potential, because it might increase the release of IL6 by binding with Toll-like receptor 4 on bone marrow adipocytes, as suggested by our MetaCore network.